Trauma Devices – Market Insights – Europe

The European trauma device market was negatively impacted by the COVID-19 pandemic to some extent, although the urgent nature of many trauma procedures limited the severity of the effect. Although the market has recovered strongly and will resume prepandemic trends in the near term, financial constraints and the increasing presence of GPOs will contribute to downward ASP pressure, limiting revenue growth to some extent. Nonetheless, favorable demographics, improved reimbursement, site-of-service flexibility, and ongoing product innovation will support procedure volumes.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in Europe from 2019 through 2032.

Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.

Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?

How are competitors expanding their offerings through product innovation, mergers, acquisitions, or partnerships to capture a larger share of the trauma device market?

Trauma surgery procedure volumes are increasing in outpatient settings.

How does site of service affect the choice of trauma device used?

Following the short-term impacts of the COVID-19 pandemic, the European trauma device market will resume modest growth.

Which product segments will see the greatest increases in unit volumes, and why?

Which segments are seeing revenue declines, and why?

How are procedural trends shifting due to improved technology and clinical data?

Table of contents